[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8,"_9":10},"actionData","errors","root",{"_103":104,"_105":58},"routes/en-gate",{"_102":58},"en-item",{"_11":12},"item",{"_13":14,"_15":16,"_17":18,"_19":-5,"_20":-5,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":27,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":-5,"_40":42,"_43":-5,"_44":-5,"_45":-5,"_46":47,"_48":-5,"_49":-5,"_50":51,"_52":53,"_54":55,"_56":38,"_57":58,"_59":-5,"_60":61,"_62":63,"_64":38,"_65":38,"_66":67},"id","e0jolrbx3eca9n5f8o3ow41nq","revision",2,"title","550+ ADCs in the clinic.","originalTitle","summary","reason","source",{"_13":97,"_78":87,"_98":99,"_100":38,"_101":-5},"links",{"_94":95,"_67":96},"publishedAt","2026-04-22T15:33:57.000Z","discoveredAt","2026-10-22T11:08:21.481Z","timelineAt","category","opinion","tags",[],"score",60,"selected",false,"channel","x","story",{"_86":87,"_88":89,"_90":-5,"_91":-5,"_92":93},"insight","digest","conferenceAbstracts","readingMode","full","author","language","body",{"_82":-5,"_67":83,"_84":-5,"_85":58},"outline",[],"relatedStories",[],"indexable","markdownAvailable",true,"group","conference",{"_76":77,"_78":79,"_80":-5,"_81":-5},"engagement",{"_68":69,"_70":71,"_72":73,"_74":75},"posterIsAuthor","hasTranslation","bodyLanguage","original","heat",81,"likes",65,"replies",3,"reposts",13,"slug","aacr-2026","name","AACR Annual Meeting 2026","topic","reading","zh","

550+ ADCs in the clinic.
14 FDA approvals.
196 already ☠️.

And we’re still relying on single-marker IHC to guide one of the most complex drugs.

The next wave of ADC success won’t come from new targets.
It will come from better patient selection.
@raffcolo #AACR26 https://t.co/Gw18jUwx23

","zhKind","complete","authorName","x.com","handle","","avatarUrl","quoted","media",[],"aihot","/items/e0jolrbx3eca9n5f8o3ow41nq","https://x.com/i/status/2046975806489219210","aacr26-floor","kind","x_search","firstParty","iconUrl","ok","changelogVersion","2026-10-23T01:25","enEditionEnabled"]